Madrigal Pharmaceuticals, Inc. Insider Transactions
Madrigal Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,900 @ $280.00 | $532,000 | 5,500 | 06/14/2024 | 06/18/2024 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 2,000 @ $285.00 | $570,000 | 5,500 | 06/12/2024 | 06/14/2024 | |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev. |
Sell | 1,036 @ $231.34 | $239,668 | 5,500 | 05/21/2024 | 05/23/2024 | |
|
CRAVES FRED B
Director |
Sell | 8,827 @ $210.99 | $1.86 M | 427,024 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 375 @ $216.08 | $81,031 | 416,283 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,000 @ $218.99 | $218,995 | 413,462 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 2,190 @ $213.85 | $468,342 | 418,462 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 5,009 @ $211.84 | $1.06 M | 422,015 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,363 @ $212.85 | $290,116 | 420,652 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,804 @ $214.68 | $387,285 | 416,658 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 721 @ $216.98 | $156,445 | 415,562 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 1,100 @ $217.86 | $239,641 | 414,462 | 05/14/2024 | 05/16/2024 | |
|
CRAVES FRED B
Director |
Sell | 100 @ $219.90 | $21,990 | 413,362 | 05/14/2024 | 05/16/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 224 @ $243.25 | $54,487 | 461,451 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 3,464 @ $247.76 | $858,241 | 190,601 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 407 @ $247.76 | $100,838 | 459,199 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 5,028 @ $246.96 | $1.24 M | 194,065 | 04/08/2024 | 04/10/2024 | |
|
FRIEDMAN PAUL A
Director |
Sell | 4,866 @ $248.59 | $1.21 M | 185,735 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 945 @ $244.79 | $231,325 | 460,506 | 04/08/2024 | 04/10/2024 | |
|
Taub Rebecca
Director, Pres., R&D, and CMO |
Sell | 600 @ $246.98 | $148,186 | 459,606 | 04/08/2024 | 04/10/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Madrigal Pharmaceuticals, Inc. FAQ's
The list of insiders at Madrigal Pharmaceuticals, Inc. includes Daly James M, BATE KENNETH, Levy Richard S, FRIEDMAN PAUL A, Taub Rebecca, CRAVES FRED B, Waltermire Robert E..
Insiders have sold a total of 279,967 Madrigal Pharmaceuticals, Inc. shares in the last 12 months for a total of 68.53 M sold.
The following insiders have sold Madrigal Pharmaceuticals, Inc. shares in the last 12 months: Daly James M ($8.22 M), BATE KENNETH ($8.21 M), Levy Richard S ($2.83 M), FRIEDMAN PAUL A ($24.45 M), Taub Rebecca ($18.68 M), CRAVES FRED B ($4.79 M), Waltermire Robert E. ($1.34 M),